TrulieveCannab - stock earnings
TRUL.CN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -403.8 million USD | 281.8 million USD |
| 2023Q1 | ? USD | 285.2 million USD |
| 2022Q4 | -77.0 million USD | 302.2 million USD |
| 2022Q3 | -114.6 million CAD | 300.8 million CAD |
| 2022Q1 | -32.0 million CAD | 318.3 million CAD |
| 2021Q4 | -71.5 million CAD | 305.3 million CAD |
| 2021Q3 | 18.6 million USD | 224.1 million USD |
| 2021Q2 | 40.9 million USD | 215.1 million USD |
| 2021Q1 | 30.1 million USD | 193.8 million USD |
TRUL.CN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -246.1 million USD | 1.2 billion USD |
| 2021 | 18.0 million CAD | 938.4 million CAD |
| 2020 | 63.0 million CAD | 521.5 million CAD |
| 2019 | 53.1 million CAD | 252.8 million CAD |
| 2018 | 10.9 million CAD | 102.8 million CAD |
TRUL.CN
Price: CA$13.19
52 week price:
Earnings Per Share: -3.09 CAD
P/E Ratio: -4.45
Exchange: CNQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 124007
Market Capitalization: 3.1 billion